Successful ECMO therapy in a child with COVID-19-associated ARDS and acute lymphoblastic leukemia

Pediatr Blood Cancer. 2021 Sep;68(9):e29100. doi: 10.1002/pbc.29100. Epub 2021 May 22.

Authors

Fabian Ebach¹, Ina Hainmann², Anna M Eis-Hübinger³, Gabriele Escherisch⁴, Dagmar Dilloo², Heiko M Reutter¹, Andreas Müller¹

Affiliations

¹ Department of Neonatology and Pediatric Intensive Care, Children's Hospital, University of Bonn, Bonn, Germany.
² Department of Pediatric Hematology and Oncology, Children's Hospital, University of Bonn, Bonn, Germany.
³ Institute of Virology, University Hospital, University of Bonn, Bonn, Germany.
⁴ Clinic of Paediatric Haematology and Oncology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

No abstract available

Publication types

Letter
Comment

MeSH terms

COVID-19*
Child
Extracorporeal Membrane Oxygenation*
Humans
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / complications
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy
Respiratory Distress Syndrome* / etiology
Respiratory Distress Syndrome* / therapy
SARS-CoV-2